Kiwi Wealth Investments Limited Partnership Dynavax Technologies Corp Transaction History

Kiwi Wealth Investments Limited Partnership

$126 Million
Q4 2023

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$7.45 - $12.83 $314,702 - $541,964	-42,242 Reduced 22.11%	148,806 $1.87 Million
Q1 2022 May 17, 2022	BUY	$9.75 - $14.44 $370,763 - $549,109	38,027 Added 24.85%	191,048 $2.07 Million
Q4 2021 Feb 15, 2022	BUY	$13.17 - $20.94 $2.02 Million - $3.2 Million	153,021 New	153,021 $2.15 Million

Others Institutions Holding DVAX

# of Institutions

275

Shares Held

130M

Call Options Held

451K

Put Options Held

203K

Black Rock Inc. New York, NY

21.9M
Shares

$283 Million
0.01% of portfolio
Deep Track Capital, LP Greenwich, CT

12.5M
Shares

$162 Million
5.15% of portfolio
Vanguard Group Inc Valley Forge, PA

9.22M
Shares

$119 Million
0.0% of portfolio
Kynam Capital Management, LP Princeton, NJ

8.33M
Shares

$107 Million
7.62% of portfolio
State Street Corp Boston, MA

7.69M
Shares

$99.2 Million
0.0% of portfolio

View Full List

About DYNAVAX TECHNOLOGIES CORP

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.63B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

More about DVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kiwi Wealth Investments Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Kiwi Wealth Investments Limited Partnership with notifications on news.

Account